Patents by Inventor Gwenda Ligon

Gwenda Ligon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11091559
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to ALK, a receptor tyrosine kinase, and modulate the expression and/or activity of ALK. Also provided are uses and methods for treating, e.g., managing, disorders, such as cancer.
    Type: Grant
    Filed: August 26, 2016
    Date of Patent: August 17, 2021
    Assignee: Celldex Therapeutics, Inc.
    Inventors: Diego Alvarado, Jay Lillquist, Gwenda Ligon, Michael Feldhaus